Trial Profile
A Phase 2 Study of KPT-330 in Metastatic Castrate Resistant Prostate Adenocarcinoma
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 14 Jan 2014
Price :
$35
*
At a glance
- Drugs Selinexor (Primary)
- Indications Bone metastases; Prostate cancer
- Focus Therapeutic Use
- 14 Jan 2014 New trial record